Sutro Biopharma, Inc. (STRO)
20.24
-0.23
(-1.12%)
USD |
NASDAQ |
Feb 27, 11:31
Sutro Biopharma Research and Development Expense (Quarterly) : 39.85M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GT Biopharma, Inc. | 0.634M |
| Rhythm Pharmaceuticals, Inc. | 45.92M |
| Crinetics Pharmaceuticals, Inc. | 89.45M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |